Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts

Monday, August 13, 2012

S&P ends longest winning streak in almost 2 years

Dow fell 38, decliners ahead of advancers almost 2-1, NAZ was up 1 & S&P 500 slid 1.  The Financial Index was even at 201.  The MLP index fell 2+ to the 289s while the REIT index was off pennies in the 262s.  Junk bond funds were mixed to lower & Treasuries were a tad higher.  Oil hardly budged & gold lost 9.

AMJ (Alerian MLP Index tracking fund)

stock chart



Click below for the latest market update:


Treasury yields:

U.S. 3-month

0.096%

U.S. 2-year

0.261%

U.S. 10-year

1.651%

CLU12.NYMCrude Oil Sep 1292.67 Down 0.20 (0.2%)

Live 24 hours gold chart [Kitco Inc.]




Merkel Doesn’t Deserve Sub-Zero Yields as Draghi Plan Gains

Photo:   Bloomberg

Chancellor Merkel's softening stance toward the ECB rescue plan for Spain & Italy is repelling investors who bought bunds because of her fiscal vigilance.  Investors seeking a haven from tumbling bond markets were willing to accept yields below zero for German bunds due in as long as 3 years because they were confident in her pledge that she wouldn’t add to the nation’s debt to expand bailout programs for weaker neighbors.  Funds managing more than $4T are turning against bunds on concern Germany’s costs to bail out the eurozone's most indebted nations will rise.  The total could reach €500B ($614B) or 45% of Germany’s current debt outstanding.  Many money euro maney managers are reducing or eliminating bund holdings.

Merkel Returns to Crisis as Bond Buying Remains in Focus


Pfizer, a Dow stock, took another step forward with a plan to spin off its animal health unit by registering the IPO with regulators.  PFE plans to sell as much as 20% of the new company, to be called Zoetis, to raise cash.  Current investors will be able to swap a portion of their PFE shares for stock in the new company.  PFE also could hold the stock for sale later.  This filing moves to complete the final announced piece of CEO Ian Read's effort to shrink the company by selling & spinning off non-drug units, which included the recent sale of its infant nutrition unit for $12B.  The stock slipped 23¢.

Pfizer Files for IPO in Plan to Spin off Animal Health

Pfizer (PFE)


stock chart


Sears plans to spin off its Hometown & Outlet stores as well as some hardware stores into a separate publicly traded company.  There are 1238 Hometown, Outlet & hardware stores, according to SHLD.  It has already closed 5 Hometown stores, 8 hardware stores & 1 Outlet store.  SHLD, which also owns Kmart, has looked at spinoffs & real estate sales to restore profitability & boost shareholder value.  Aside from the separation of the stores, the company announced in May that it would spin off a stake in its Canada division.  SHLD expects to raise $346M with the spin-off.  Previously it said that it expected the deal to raise between $400-$500M.  A cash dividend of $100M is also expected to be paid to SHLD.  For fiscal 2011, the combined Sears Hometown, hardware & Outlet businesses had net income of $33M on sales of about $2.34B, below 2010 net income of $49B on sales of approximately $2.35B.  The stock rose $3 (6%).

Sears Spinning Off Some Stores Into Separate Co.

Sears Holdings (SHLD)


stock chart


Stocks fell, with the S&P 500 Index (barely) halting its longest rally since 2010, while Treasuries rose amid concern about slowing Asian growth.  Dow was down 100 & the S&P 500 was down 9 at their lows, but buying in the PM limited the losses by day's end.  The € gained a fraction to over $1.23, up only a couple of pennies from recent lows. Overall this rates as a lackluster day, a lazy summer day with many away on holiday.  But euro leaders, among others, will be returning soon, adding excitement to the markets.

Dow Jones Industrials


stock chart





Get your favorite symbols' Trend Analysis TODAY!  



Tuesday, July 31, 2012

Markets slip lower while waiting FOMC decision tomorrow

Dow lost 64 (closing at the lows), decliners ahead of advancers 5-4 & NAZ was off 6 even though Apple (AAPL) shot up 15.  The Financial Index remained fractonally lower in the 197s.  The MLP index was off 1+ to the 393s & the REIT index fell a fraction in the 267s.  Junk bond funds were mixed near their yearly highs & Treasuries edged higher.  Oil tumbled below $90, giving up some its recent gains & gold pulled back modestly.

AMJ (Alerian MLP Index tracking fund)


stock chart



Click below for the latest market update:


CLU12.NYMCrude Oil Sep 1288.07 Down 1.71 (1.9%)

Treasury yields:

U.S. 3-month

0.101%

U.S. 2-year

0.215%

U.S. 10-year

1.495%


Live 24 hours gold chart [Kitco Inc.]




China will step up policy fine-tuning in H2 to support economic growth, although there are signs of stabilization in the economy, the official Xinhua news agency quoted Premier Wen Jiabao as saying.  Wen affirmed the gov's resolve to maintain its long-standing controls on the property sector.  The gov will take steps to improve the domestic investment environment & diversify its export market.  China would also increase fiscal & monetary policy support to the economy in H2.  The comments were made with business leaders & academics, including former World Bank chief economist Justin Lin.  These comments are broadly in line with official pro-growth statements made in the wake of H1 GDP data which showed the economy in Q2 had expanded at its slowest pace in more than 3 years.  The Chinese economy needs a little extra juice.

China Reiterates Growth Chief Priority


Pfizer Schedules Animal Unit IPO as Profit Beats Estimates

Photo:   Bloomberg

Pfizer, a Dow stock, posted a 25% jump in Q2 net income due to aggressive cost cutting & lower restructuring & other charges, shaking off the expected plunge in revenue from generic competition to cholesterol fighter Lipitor, the world's top-selling drug.  EPS was 43¢, up from 33¢ last year.  Excluding $2.1B in charges before taxes, adjusted EPS was 62¢, 8¢ above the forecast.  Charges included $1.2B for asset writedowns & $474M in legal charges, mainly for litigation over its hormone replacement medicines.  Revenue totaled $15.06B, down 9% but above expectations of $14.93B.  Generic competition reduced sales by about $1.8B, mainly because of lower Lipitor sales (which had peak annual global sales of $13B).  Early sales losses were slowed by the unprecedented strategy to keep patients on its brand as long as possible.  In Q2, US Lipitor sales nosedived to $296M from $1.4B a year ago & global sales slumped 53%to $1.2B.  Still, "We kept three times more (market) share than has traditionally occurred" after a big drug's patent expired, CEO Ian Read said.  "We added hundreds of millions of dollars of profitability to the company, as well as enabling patients to stay on the brand."  Newer drugs, particularly pain reliever Lyrica and Prevnar 13 saw sales jump just over 10%.  Total pharmaceutical sales fell 10%, to $13.1B.  Sales of veterinary medicines edged up 3% to $1.09B & sales of consumer health care products, such as ChapStick & Centrum vitamins, increased 8% to $768M.  PFE expects action from the FDA soon on 2 experimental drugs that have run into trouble.  PFE will file in mid-Aug to sell as much as 20% of its animal-health unit in an IPO.  The stock rose 38¢ & has a good chart over the last year.

Pfizer Plans August IPO Filing as Profits Top Estimates

Pfizer (PFE)


stock chart


Enbridge Energy Partners, a major MLP, Q2 earnings fell 28% on lower selling prices for natural gas liquids.  Results were below expectations for adjusted earnings & revenue.  Earnings were 33¢ per unit compared with 51¢ a year earlier.  Excluding items such as hedging gains, it would have earned 23¢ per unit.  The forecast was for earnings of 31¢ per unit.  Revenue plunged 35% to $1.55B from $2.37B last year ago & well below the $1.77B forecast.  The recent price drop in natural gas liquids was partly offset by higher pipeline revenue.  EEP also announced that it will increase the quarterly distribution to 54.35¢ per unit, a 2.1% increase that was in line with its goal of raising annual distributions by 2-5%.  EEP also has a companion corp, EEQ, which tracks the price of the units & pays a stock div based on the distribution.  The units rose 79¢.

Enbridge 2Q profit, sales fall on lower gas prices AP

Enbridge Energy Partners (EEP)


stock chart


This was another listless day as markets wait for the results of the Federal Reserve meeting tomorrow.  The following day, ECB will make a much bigger announcement.  Everybody is guessing what actions it can take to ease the euro debt mess.  Another round of bond buying is expected.  But it has just so much money, not to mention, when it ends, market forces will probably drag bond prices down, forcing yields up.  Dow gained 128 in Jul & remains above 13K, important for those watching technical signs.

Dow Jones Industrials


stock chart






Get your favorite symbols' Trend Analysis TODAY!  



Tuesday, May 1, 2012

Higher markets on better than expected April auto sales

Dow rose 93 to new highs not seen since 2008, advancers ahead of decliners 4-1 & NAZ gained 33.  Bank stocks led the charge with the Financial Index up 3+ to 211 (one month high).  The MLP index continues on its winning ways, up a fraction to 399, & the REIT index rose 3+ to almost 264, a new high since the middle or 2008.   Junk bond funds inched higher while Treasuries pulled back after recent gains.  Oil & gold are marking time.

JPMorgan Chase Capital XVI (AMJ)


stock chart

Treasury yields:

U.S. 3-month

0.097%

U.S. 2-year

0.262%

U.S. 10-year

1.937%

CLM12.NYM...Crude Oil Jun 12...104.75 ...Down 0.12  (0.1%)

GCK12.CMX...Gold May 12......1,667.60 ...Up 4.20  (0.3%)



Get the latest daily market update below:



Construction spending barely rose in Mar as investment in public projects dropped to a 5-year low, according the Commerce Dept which could see the Q1 economic GDP estimate lowered.  Construction spending edged up 0.1% to an annual rate of $808B, after a revised 1.4% drop in Feb.  Expectations had been for construction spending to rise 0.5% after a previously reported 1.1% decline in Feb.  But overall construction spending was up 6% compared to Mar 2011.  Private construction spending increased 0.7% after falling 1.9% in Feb.  Spending on residential projects rose 0.7%, partly reflecting home improvements.  Investment in multifamily residential projects fell 3.1%, while outlays for single-family buildings increased 3.8%.  Residential construction grew at its fastest pace since Q2 2010.  Private nonresidential construction rebounded 0.7% in Mar, breaking 2 straight months of declines.  Spending on public sector construction fell 1.1% to $276B, the lowest level since Feb 2007 as outlays on state & local gov projects dropped 1.6% to the lowest level since Nov 2006.  More mixed data on this important sector for the economy.

Construction Spending Up, Investment in Public Projects Hits Five Year Low

Reuters

Pfizer Beats Estimates

Photo:   Bloomberg

Pfizer, a Dow stock, reported higher-than-expected quarterly earnings as improved profit margins & strong sales of its Lyrica nerve-pain drug partly offset plunging demand for its Lipitor cholesterol fighter which is facing cheaper generic rivals.  Sales of Lipitor fell 42% to $1.4B.  EPS was 24¢ compared with 28¢ last year (when results suffered because of a litigation charge & costs of revamping research operations).  Excluding special charges to boost productivity & address legal matters, Pfizer earned 58¢, compared with 60¢ last year but better than 56¢ expected.  PFE is now eagerly awaiting US approvals of 2 potential blockbuster treatments: blood clot preventer Eliquis & tofacitinib to treat rheumatoid arthritis.  In the meantime, it's squeezing growth out of older medicines, including Lyrica, whose sales jumped 16% to almost $1B, fueled by growing demand in Japan.  Sales of painkiller Celebrex rose 7% to $634M, while sales of arthritis treatment Enbrel rose 3% to $899M.  Premarin, its line of female hormone replacement drugs, topped forecasts, with sales rising 11% to $261M.  But sales of its Prevnar vaccines against pneumonia & other infections fell 6% to $941M due to fewer children getting booster shots during the period & a lower US birth rate for eligible patients versus a year ago.  Total revenue fell 7% to $15.4B, just below expectations of $15.47B.  The stock fell 13¢.

Pfizer Profit Beats Estimates as Drugmaker Readies Animal Health Spin-Off

Pfizer, Inc. (PFE)


stock chart


Chrysler Group April U.S. Sales Up 20%

Photo:   Bloomberg

Chrysler, Ford & General Motors reported Apr sales that exceeded estimates.  Chrysler sales climbed 20% to 141K light vehicles.  Ford deliveries slipped 5.1% to 179K cars & light trucks, & GM sales fell 8.2% to 213K.  But they beat estimates of a 16% gain for Chrysler, 5.7% drop for Ford & 9% decline for GM.  Chrysler added 2.1 percentage points of market share in Q1 compared with a year earlier and has reported 11 consecutive months of year-over-year sales gains exceeding 20%.  CEO Marchionne is counting on the new Dodge Dart compact, which begins production this week, to boost deliveries later this year after a 5-month streak of 30% sales gains.  Toyota's (TM) US light vehicle sales rose 12%, better than the average estimate for a 10% gain.  GM also raised its forecast for full-year US light-vehicle sales to 14-14.5M, up from 14M.  The company cited “higher than expected” Q1 industry sales & expectations the US economy will keep growing.  Autos are leading the strong manufacturing performance in the US.

Chrysler Leads U.S. Automakers Beating Sales Estimates

General Motors Company (GM)


stock chart

Ford Motor Company (F)


stock chart


The bulls are back from their long holiday weekend & bidding up prices.  Bank stocks deserve special attention with prices near highs reached on at the end of Mar.  MLPs are also recovering after a sluggish period in Mar & much of Apr.  And REITs are at multi year highs.  Europe debts woes have vanished, although Spain looks iffy, & a slowdown in the US economy does not bother investors.  Dow is at a 4 year high, making the bulls very happy.

Dow Industrials


stock chart








Get your favorite symbols' Trend Analysis TODAY!